| Product NDC: | 50332-0127 |
| Proprietary Name: | Relief-PE |
| Non Proprietary Name: | ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE |
| Active Ingredient(s): | 325; 2; 5 mg/1; mg/1; mg/1 & nbsp; ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50332-0127 |
| Labeler Name: | NorMed |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part343 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20120416 |
| Package NDC: | 50332-0127-4 |
| Package Description: | 100 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0127-4) |
| NDC Code | 50332-0127-4 |
| Proprietary Name | Relief-PE |
| Package Description | 100 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0127-4) |
| Product NDC | 50332-0127 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120416 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | NorMed |
| Substance Name | ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 325; 2; 5 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |